Abstract
The lung is unique among the visceral organs because it is exposed to the external environment. Remarkably, there is continuity between the tip of the nostril and the most distal alveoli. Thousands of cubic feet of air pass through the airways each day, air that contains noxious gases, dusts, particulate material, and microbial organisms that alone or in combination can damage the lung. Fortunately, the lung has multiple defense mechanisms that protect against potentially injurious agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Verhoef J. Host-pathogen relationships in respiratory tract infections. Clin Ther 1991; 13 (1): 172–180.
Coonrod JD, Rehm SR, Yoneda K. Pneumococcal killing in the alveolus. Evidence for a nonphagocytic defense mechanism for early clearance. Chest 1983; 83 (Suppl.): 895–905.
Jonsson S, Musher DM, Goree A, Lawrence EC. Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis 1986; 133 (1): 136–140.
Reynolds HY. Lung inflammation: Role of endogenous chemotactic factors in attracting polymorphonuclear granulocytes. Am Rev Respir Dis 1983; 127 (2): S16–S25.
Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141 (2): 471–501.
Fisher ES, Lauffenburger DA, Daniele RP. The effect of alveolar macrophage Chemotaxis on bacterial clearance from the lung surface. Am Rev Respir Dis 1988; 137 (5): 1129–1134.
Valberg PA, Jensen WA, Rose RM. Cell organelle motions in bronchoalveolar lavage macrophages from smokers and nonsmokers. Am Rev Respir Dis 1990; 141: 1272–1279.
Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984; 150 (5): 752–760.
Elstad MR. Aspergillosis and lung defenses. Semin Respir Infect 1991; 6 (1): 27–36.
Flesch IE, Schwamberger G, Kaufmann SH. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol 1989; 142 (9): 3219–3224.
Tuomanen E, Rich R, Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 1987; 135 (4): 869–874.
Harris SE, Nelson S, Astry CL, Bainton BG, Summer WR. Endotoxin-induced suppression of pulmonary antibacterial defenses against Staphylococcus aureus. Am Rev Respir Dis 1988; 138 (6): 1439–1443.
Levi MH, Pasculle AW, Dowling JN. Role of the alveolar macrophage in host defense and immunity to Legionella micdadei pneumonia in the guinea pig. Microb Pathog 1987; 2 (4): 269–282.
Debs RJ, Fuchs HJ, Philip R, et al. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. J Immunol 1988; 140 (10): 3482–3488.
Rhodin AJ. The ciliated cell. Ultrastructure and function of the human tracheal mucosa. Amer Ref Resp Dis 1966; 93: 1–15.
Dalhamn T. Mucus flow and ciliary activity in the trachea of healthy rats and rats exposed to respiratory irritant gases. Acta Physiol Scand (Suppl. 123) 1956; 36: 1–163.
Iravani J, Van As A. Mucus transport in the tracheobronchial tree of normal and bronchitic rats. J Pathol 1972; 106: 81–93.
Sleigh MA. The nature and action of respiratory tract cilia. In: Brain J, Proctor D, Reid L, ed. Respiratory defense mechanisms. New York: Dekker, 1977: 247–289.
Fick RB, Jr. Cell-mediated antibacterial defenses of the distal airways. Am Rev Respir Dis 1985; 131 (5): 543–548.
Lipscomb MF. Lung defenses against opportunistic infections. Chest 1989; 96 (6): 1393–1399.
Dannenberg AJ. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991; 12 (7): 228–233.
Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988; 137 (6): 1268–1274.
Hoffman RM, Dauber JH, Paradis IL, Griffith BP, Hard-esty RL. Alveolar macrophage migration after lung transplantation. Am Rev Respir Dis 1991; 143: 834–838.
Iwata M, Sato A. Morphological and immunohistochem-ical studies of the lungs and bronchus-associated lymphoid tissue in a rat model of chronic pulmonary infection with Pseudomonas aeruginosa. Infect Immun 199 l;p59(4): 1514–1520.
Toews GB, Hansen EJ, Strieter RM. Pulmonary host defenses and oropharyngeal pathogens. Am J Med 1990; 88 (5A): 205–245.
Shennib H, Mulder DS, Chiu RC. The effects of pulmonary atelectasis and reexpansion on lung cellular immune defenses. Arch Surg 1984; 119 (3): 274–277.
Marshall BC, Carroll KC. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis. Semin Respir Infect 1991; 6 (1): 11–18.
Siewert A. Uber einen fall von bronchiectasie bei einem patienten mit situs inversus viscerum. Berl Klin Wochen-schr 1904; 41: 139–141.
Kartagener M. Zur Pathogenese der bronchiektasien. I. Mitteilung: Bronchiektasien bei situs viscerum inversus. Beitr Klin Tuberk 1933, 83: 498–501.
Afzelius BA. A human syndrome caused by immotile cilia. Science 1976; 193: 317–319.
Afzelius BA, Eliasson R. Flagellar mutants in man: On the heterogeneity of the immotile-cilia syndrome. J Ultra-struct Res 1979; 69: 43–52.
Afzelius BA. The immotile cilia syndrome and other ciliary diseases. Int Rev Exp Pathol 1979; 19: 1–43.
Sturgess J, Thompson M, Czegledy-Nagy E, Turner J. Genetic aspects of immotile cilia syndrome. Am J Med Genet 1986; 25: 149–160.
Afzelius BA. Disorders of ciliary motility. Hosp Pract 1986; 21 (3): 73–80.
Pavia D, Agnew JE, Bateman JRM, et al. Lung mucociliary clearance in patients with Young’s syndrome. Chest 1981; 80: 892–893.
Waite DA, Wakefield SJ, MackayJB, Ross IT. Mucociliary transport and ultrastructural abnormalities in Polynesian bronchiectasis. Chest 1981; 80 (Suppl): 896–898.
Douglas SD, Musson RA. Phagocytic defects—monocytes/ macrophages. Clin Immunol Immunopathol 1986; 40(l):62–68.
Quie PG. Lung defense against infection. J Pediatr 1986; 108: 813–816.
White JC, Nelson S, Winkelstein JA, Booth FV, Jakab GJ. Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection. J Infect Dis 1986; 153 (2): 202–208.
Nelson S, Chidiac C, Bagby G, Summer WR. Endotoxin-induced suppression of lung host defenses. J Med (West-bury) 1990; 21 (1–2): 85–103.
Ozaki T, Maeda M, Hayashi H, et al. Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog. Am Rev Respir Dis 1989; 140 (6): 1595–1601.
Pennington JE, Rössing TH, Boerth LW, Lee TH. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor. J Clin Invest 1985; 75 (4): 1230–1237.
Ehouman A, Pinchon MC, Escudier E, Bernaudin JF. Ultrastructural abnormalities of respiratory cilia. Vir-chows Arch B Cell Pathol 1985; 48: 87–95.
Rosenow EC, III, Wilson WR, Cockerill FR, III. Pulmonary disease in the immunocompromised host. 1. Mayo Clin Proc 1985*;60(7):473–487.
Martin TR, Altman LC, Alvares OF. The effects of severe protein-calorie malnutrition on antibacterial defense mechanisms in the rat lung. Am Rev Respir Dis 1983; 128 (6): 1013–1019.
Shellito J, Suzara VV, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990; 85 (5): 1686–1693.
Robinson A, Abraham E. Hemorrhage in mice produces alterations in pulmonary B cell repertoires. J Immunol 1990; 145 (11): 3734–3739.
Musher DM, Watson DA, Nickeson D, Gyorkey F, Lahart C, Rossen RD. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med Sei 1990; 299 (3): 158–163.
Wallaert B, Aerts C, Bart F, et al. Alveolar macrophage dysfunction in systemic lupus erythematosus. Am Rev Respir Dis 1987; 136 (2): 293–297.
Weissler JC, Nicod LP, Toews GB. Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. Am Rev Respir Dis 1987; 135 (6): 1353–1357.
Callery MP, Kamei T, Mangino MJ, Flye MW. Organ interactions in sepsis. Host defense and the hepatic-pulmonary macrophage axis. Arch Surg 1991; 126(1):28— 32.
Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bron-choalveolar macrophage defense against Rhizopus. J Clin Invest 1984; 74 (1): 150–160.
Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990; 39 (3): 271–275.
Sima AA, O’Neill SJ, Naimark D, Yagihashi S, Klass D. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes 1988; 37 (5): 544–549.
Mellencamp MA, Preheim LC. Pneumococcal pneumonia in a rat model of cirrhosis: Effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. Infect Dis 1991; 163 (1): 102–108.
Martin TR, Pistorese BP, Hudson LD, Maunder RJ. The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am Rev Respir Dis 1991; 144 (2): 254–262.
Binkhorst GJ, Henricks PA, VD Inghts, Hajer R, Nijkamp FP. The effect of stress on host defense system and on lung damage in calves experimentally infected with Pasteurella haemolytica type Al. Zentralbl Veterinaemed Reihe A 1990; 37 (7): 525–536.
Sisson JH, Tuma DJ, Rennard SI. Acetaldehyde-medi-ated cilia dysfunction in bovine bronchial epithelial cells. Am J Physiol 1991; 260: L29–L36.
Gilmour MI, Hmieleski RR, Stafford EA, Jakab GJ. Suppression and recovery of the alveolar macrophage phagocytic system during continuous exposure to 0.5 ppm ozone. Exp Lung Res 1991; 17 (3): 547–588.
Nelson S, Summer WR, Jakab GJ. Aminophylline-in-duced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 1985; 131 (6): 923–927.
Nelson S, Summer WR, Terry PB, Warr GA, Jakab GJ. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. Am Rev Respir Dis 1987; 136 (5): 1207–1212.
Shayevitz JR, Varani J, Ward PA, Knight PR. Halothane and isoflurane increase pulmonary artery endothelial cell sensitivity to oxidant-mediated injury. Anesthesiology 1991; 74 (6): 1067–1077.
Reynolds HY. Lung Inflammation: Normal host defense or a complication of some diseases? Annu Rev Med 1987; 38 (l): 295–323.
Sherman MP, Evans MJ, Campbell LA. Prevention of pulmonary alveolar macrophage proliferation in newborn rabbits by hyperoxia. J Pediatr 1988; 112 (5): 782–786.
Hubbard RC, McElvaney NG, Sellers SE, Healy JT, Czer-ski DB, Crystal RG. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha-1-antitrypsin deficiency. J Clin Invest 1989; 84 (4): 1349–1354.
Sanderson M, Dirksen E. Mechanosensitive and beta-adrenergic control of the ciliary beat frequency of mammalian respiratory tract cells in culture. Am Rev Respir Dis 1989; 139: 432–440.
Yeates D, Spektor D, Pitt B. Effect of orally administered orciprenaline on tracheobronchial mucociliary clearance. Eur J Respir Dis 1986; 69: 100–108.
Foster WM, Langenback E, Bohning DE, Bergofsky EH. Quantitation of mucus clearance in peripheral lung and comparison with tracheal and bronchial mucus transport velocities in man: Adrenergics return depressed clearance and transport velocities in asthmatics to normal. Am Rev Respir Dis 1978;l77(Suppl.):337 (abstr.).
Wanner A, Maurer D. Abraham W, Szepfalusi Z, Sielczak M. Effects of chemical mediators of anaphylaxis on ciliary function. J Allergy Clin Immunol 1983; 72: 663–667.
Mussatto D, Lourenco R. The effect of inhaled histamine on human tracheal mucus velocity and bronchial mucociliary clearance. Am Rev Respir Dis 1988; 138: 775–779.
Bisgaard H, Pedersen M. SRS-A leukotrienes decreases the activity of human respiratory cilia. Clin Allergy 1987; 17: 95–103.
Tamaoki J, Kobayaski K, Sakai N, Chiyotani A, Kane-mura T, Takizawa T. Effect of bradykinin on airway ciliary motility and its modulation by neutral endopepti-dase. Am Rev Respir Dis 1989; 140: 430–435.
Lindberg S, Mercke U. Bradykinin accelerates mucociliary activity in rabbit maxillary sinus. Acta Otolaryngol (Stockh) 1988; 101: 114–121.
Wong L, Miller I, Yeates D. Regulatory pathways for the stimulation of canine tracheal ciliary beat frequency by bradykinin. J Physiol (London) 1990; 422: 421–431.
Kondo M, Tamaoki J, Takizawa T. Neutral endopeptid-ase inhibitor potentiates the tachykinin-induced increase in ciliary beat frequency in rabbit trachea. Am Rev Respir Dis 1990; 142: 403–406.
Kobayashi K, Tamaoki J, Sakai N, Kanemura T, Horii S, Takizawa T. Angiotensin II stimulates airway ciliary motility in rabbit cultured tracheal epithelium. Acta Physiol Scand 1990; 138: 497–502.
Khan A, Bengtsson B, Lindberg S. Influence of substance P on ciliary beat frequency in airway isolated preparations. Eur J Pharmacol 1986; 130: 91–96.
Lindberg S, Mercke U, Uddman R. The morphological basis for the effect of substance P on mucociliary activity in rabbit maxilliary sinus. Acta Otolaryngol (Stockh) 1986; 101: 314–319.
Dadaina J, Yin S, Laurenzi G. Studies of mucus flow in the mammalian respiratory tract. Am Rev Respir Dis 1971; 103: 808–815.
Verdugo P. Calcium-dependent hormonal stimulation of ciliary activity. Nature (London) 1980; 283: 764–765.
Wanner A, Sielczak M, Mella J, Abraham W. Ciliary responsiveness in allergic and nonallergic airways. J Appl Physiol 1986; 60: 1967–1971.
Villalon M, Hinds T, Verdugo P. Stimulus-response coupling in mammalian ciliated cells. Demonstration of two mechanisms of control for cytosolic [Ca2+]. Biophys J 1989; 56: 1255–1258.
Jonsson MS, McCormick JR, Gillies CG, Gondos B. Kart-agener’s syndrome with motile spermatozoa. N Engl J Med 1982; 307: 1131–1133.
Sturgess JM, ChaoJ, Wong J, Aspin N, Turner JAP. Cilia with defective radial spokes—A cause of human respiratory disease. N Engl J Med 1979; 300: 53–56.
Sturgess J M, ChaoJ, Turner J A. Tranposition of ciliary microtubules. Another cause of impaired ciliary motility. N Engl J Med 1980; 303: 318–322.
Schneeberger EE, McCormack J, Issenberg HJ, Schuster SR, Gerald PS. Heterogeneity of ciliary morphology in the immotile-cilia syndrome in man. J Ultrastruct Res 1980; 73: 34–43.
Afzelius BA, Camner P, Mossberg B. Acquired ciliary defects compared to those seen in the immotile-cilia syndrome. Eur J Respir Dis 1983; 64: 5–10.
Carson JL, Collier AM. Ciliary defects: Cell biology and clinical perspectives. Adv Pediatr 1988; 35: 139–165.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Linder, J., Sisson, J.H. (1994). Lung Defenses. In: Dail, D.H., Hammar, S.P. (eds) Pulmonary Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3935-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3935-0_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-3937-4
Online ISBN: 978-1-4757-3935-0
eBook Packages: Springer Book Archive